<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Claritas Pharmaceuticals Inc — News on 6ix</title>
    <link>https://6ix.com/company/claritas-pharmaceuticals-inc</link>
    <description>Latest news and press releases for Claritas Pharmaceuticals Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 07 Apr 2022 11:31:24 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/claritas-pharmaceuticals-inc" rel="self" type="application/rss+xml" />
    <item>
      <title>Claritas Announces Approval from OTC to Up-List to OTCQB</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/claritas-announces-approval-from-otc-to-up-list-to-otcqb</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/claritas-announces-approval-from-otc-to-up-list-to-otcqb</guid>
      <pubDate>Thu, 07 Apr 2022 11:31:24 GMT</pubDate>
      <description>Claritas Announces Approval from OTC to Up-List to OTCQB.</description>
    </item>
    <item>
      <title>Claritas Announces Approval from Australian Ethics Committee to Begin Phase 1 Trial of R-107</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/claritas-announces-approval-from-australian-ethics-committee-to-begin-phase-1-trial-of-r-107</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/claritas-announces-approval-from-australian-ethics-committee-to-begin-phase-1-trial-of-r-107</guid>
      <pubDate>Tue, 05 Apr 2022 11:16:39 GMT</pubDate>
      <description>Claritas Announces Approval from Australian Ethics Committee to Begin Phase 1 Trial of R-107.</description>
    </item>
    <item>
      <title>BCSC-OSC Revocation of Cease Trade Order</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/bcsc-osc-revocation-of-cease-trade-order</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/bcsc-osc-revocation-of-cease-trade-order</guid>
      <pubDate>Fri, 22 Jan 2021 05:00:00 GMT</pubDate>
      <description>BCSC-OSC Revocation of Cease Trade Order.</description>
    </item>
    <item>
      <title>BCSC-OSC Partial Revocation of Cease Trade Order</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/bcsc-osc-partial-revocation-of-cease-trade-order</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/bcsc-osc-partial-revocation-of-cease-trade-order</guid>
      <pubDate>Tue, 14 Jul 2020 04:00:00 GMT</pubDate>
      <description>BCSC-OSC Partial Revocation of Cease Trade Order.</description>
    </item>
    <item>
      <title>BCSC Cease Trade Order</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/bcsc-cease-trade-order-6</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/bcsc-cease-trade-order-6</guid>
      <pubDate>Mon, 22 Jun 2020 04:00:00 GMT</pubDate>
      <description>BCSC Cease Trade Order.</description>
    </item>
    <item>
      <title>Kalytera Announces Binding Agreement to Acquire Salzman Group</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-binding-agreement-to-acquire-salzman-group</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-binding-agreement-to-acquire-salzman-group</guid>
      <pubDate>Tue, 19 May 2020 12:51:12 GMT</pubDate>
      <description>Kalytera Announces Binding Agreement to Acquire Salzman Group.</description>
    </item>
    <item>
      <title>Kalytera Announces Updates to Its Annual and Interim Filings</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-updates-to-its-annual-and-interim-filings</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-updates-to-its-annual-and-interim-filings</guid>
      <pubDate>Tue, 28 Apr 2020 20:50:14 GMT</pubDate>
      <description>Kalytera Announces Updates to Its Annual and Interim Filings.</description>
    </item>
    <item>
      <title>Kalytera and Stero Biotechs Will Not Proceed with Acquisition</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-and-stero-biotechs-will-not-proceed-with-acquisition</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-and-stero-biotechs-will-not-proceed-with-acquisition</guid>
      <pubDate>Mon, 13 Apr 2020 20:49:10 GMT</pubDate>
      <description>Kalytera and Stero Biotechs Will Not Proceed with Acquisition.</description>
    </item>
    <item>
      <title>Kalytera Provides Additional Detail Regarding Terms of Stero Biotechs, Ltd. Acquisition</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-provides-additional-detail-regarding-terms-of-stero-biotechs-ltd-acquisition</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-provides-additional-detail-regarding-terms-of-stero-biotechs-ltd-acquisition</guid>
      <pubDate>Wed, 18 Mar 2020 21:29:11 GMT</pubDate>
      <description>Kalytera Provides Additional Detail Regarding Terms of Stero Biotechs, Ltd. Acquisition.</description>
    </item>
    <item>
      <title> Kalytera Announces Extension of Maturity Date of Promissory Note</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-extension-of-maturity-date-of-promissory-note</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-extension-of-maturity-date-of-promissory-note</guid>
      <pubDate>Mon, 16 Mar 2020 12:17:45 GMT</pubDate>
      <description>Kalytera Announces Extension of Maturity Date of Promissory Note.</description>
    </item>
    <item>
      <title>Kalytera Announces Trading Halt</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-trading-halt</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-trading-halt</guid>
      <pubDate>Thu, 05 Mar 2020 22:15:41 GMT</pubDate>
      <description>Kalytera Announces Trading Halt.</description>
    </item>
    <item>
      <title>Kalytera to Acquire Stero Biotechs, Ltd.</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-to-acquire-stero-biotechs-ltd</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-to-acquire-stero-biotechs-ltd</guid>
      <pubDate>Thu, 05 Mar 2020 13:17:46 GMT</pubDate>
      <description>Kalytera to Acquire Stero Biotechs, Ltd..</description>
    </item>
    <item>
      <title>Kalytera Announces Modification to Sale Period for Shares Issued under Payments Agreement</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-modification-to-sale-period-for-shares-issued-under-payments-agreement</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-modification-to-sale-period-for-shares-issued-under-payments-agreement</guid>
      <pubDate>Thu, 20 Feb 2020 04:08:41 GMT</pubDate>
      <description>Kalytera Announces Modification to Sale Period for Shares Issued under Payments Agreement.</description>
    </item>
    <item>
      <title>Kalytera Completes Share Issuance under Payments Agreement</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-completes-share-issuance-under-payments-agreement</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-completes-share-issuance-under-payments-agreement</guid>
      <pubDate>Wed, 19 Feb 2020 05:03:09 GMT</pubDate>
      <description>Kalytera Completes Share Issuance under Payments Agreement.</description>
    </item>
    <item>
      <title>Kalytera Announces New Payments Agreement with the Salzman Group of Israel</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-new-payments-agreement-with-the-salzman-group-of-israel</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-new-payments-agreement-with-the-salzman-group-of-israel</guid>
      <pubDate>Fri, 07 Feb 2020 23:10:11 GMT</pubDate>
      <description>Kalytera Announces New Payments Agreement with the Salzman Group of Israel.</description>
    </item>
    <item>
      <title>Kalytera Announces Notice of Allowance of Additional U.S. Patent for Prevention and Treatment of Graft Versus Host Disease</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-notice-of-allowance-of-additional-us-patent-for-prevention-and-treatment-of-graft-versus-host-disease</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-notice-of-allowance-of-additional-us-patent-for-prevention-and-treatment-of-graft-versus-host-disease</guid>
      <pubDate>Wed, 05 Feb 2020 13:45:41 GMT</pubDate>
      <description>Kalytera Announces Notice of Allowance of Additional U.S. Patent for Prevention and Treatment of Graft Versus Host Disease.</description>
    </item>
    <item>
      <title>Kalytera Announces Intention to Seek Amendment of Secured Convertible Debentures Due December 2019</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-intention-to-seek-amendment-of-secured-convertible-debentures-due-december-2019</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-intention-to-seek-amendment-of-secured-convertible-debentures-due-december-2019</guid>
      <pubDate>Sat, 21 Dec 2019 00:11:10 GMT</pubDate>
      <description>Kalytera Announces Intention to Seek Amendment of Secured Convertible Debentures Due December 2019.</description>
    </item>
    <item>
      <title>Kalytera Announces Extension of Maturity Date of Promissory Note</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-extension-of-maturity-date-of-promissory-note-1</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-announces-extension-of-maturity-date-of-promissory-note-1</guid>
      <pubDate>Mon, 16 Dec 2019 13:14:16 GMT</pubDate>
      <description>Kalytera Announces Extension of Maturity Date of Promissory Note.</description>
    </item>
    <item>
      <title>Kalytera Reports Third Quarter 2019 Financial Results</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-reports-third-quarter-2019-financial-results</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/kalytera-reports-third-quarter-2019-financial-results</guid>
      <pubDate>Mon, 02 Dec 2019 13:43:14 GMT</pubDate>
      <description>Kalytera Reports Third Quarter 2019 Financial Results.</description>
    </item>
    <item>
      <title>Published Studies Provide Further Support For Kalytera’s Program Evaluating CBD in GVHD</title>
      <link>https://6ix.com/company/claritas-pharmaceuticals-inc/news/published-studies-provide-further-support-for-kalyteras-program-evaluating-cbd-in-gvhd</link>
      <guid isPermaLink="true">https://6ix.com/company/claritas-pharmaceuticals-inc/news/published-studies-provide-further-support-for-kalyteras-program-evaluating-cbd-in-gvhd</guid>
      <pubDate>Fri, 22 Nov 2019 13:42:11 GMT</pubDate>
      <description>Published Studies Provide Further Support For Kalytera’s Program Evaluating CBD in GVHD.</description>
    </item>
  </channel>
</rss>